生物技术产业

• The jingfeida industrial zonc is located in the tamous " home - town of electric tools " - xiejia township , gaoyou city . the under taker is the jingfeida group
  该区规划面积5000亩，重点发展农副产品深加工及生物技术产业等。
• Biotechnology , marked by its environmental protection , low input and high output , has become a high priority of the governments " concern world - wide
  生物技术产业以其环保，低投入、高产出而成为各国优先发展的行业新贵。
• When i spoke at the royal society in may 2002 , i talked about the strength of our biotechnology industry and our plans for supporting the emerging nanotechnology industry
  2002年5月在皇家学会的演讲中，我谈到了我们生物技术产业的实力以及支持新兴的纳米技术产业的计划。
• St . gallen , switzerland ( reuters ) - u . n . secretary - general kofi annan warned that potential dangers from the rapidly growing biotechnology industry were increasing exponentially and urged creating global safeguards
  瑞士（路透社） -联合国秘书长科菲?安南告诫说迅速发展的生物技术产业带来的潜在危险呈指数增长，迫切需要全球防御。
• The australian stem cell centre is a major australian collaborative initiative uniting many of the country ' s leading academic researchers with the biotechnology industry to develop innovative therapeutic products to treat a range of serious injuries and debilitating diseases
  澳大利亚干细胞中心与本国许多专家合作，并与生物技术产业联合，开发新的治疗产品，用以治疗各种疾患
• As discussed in utility , the author reviews the process of the evolvement of the requirment of utility in the united states and point out the trend to integrate the standard of utility to fullfill the demand of the biochemistry industry
  就实用性而言，笔者回顾了在美国dna序列实用性判断标准的历史演变历程;由于生物产业利益的导向始终挤压着法律理念的正常逻辑，为顺应生物技术产业的要求而存在着不断降低实用性要求的趋向。
• National yang - ming medical college was granted university status by the ministry of education and renamed the national yang - ming university with schools of medicine , medical technology , life sciences and the center for general education , the institute of biochemistry and molecular biology became one of the component institutes of the school of life sciences
  暨分子生物研究所现阶段之使命，乃是要顺应生命科学发展之潮流，以提升国内生物化学分子生物生物医学研究水准，培育优秀研究人才，协助国家生物技术产业之发展为己任。
• Moreover , government should do further reform on the system of science and technology ; consolidate the establishment of technology innovation system ; perfect regulations , increase investment , enhance the protection of intellectual property rights ; increase investment for fundamental research , encourage to combine the study for innovation and the research on industrialization ; make attractive rules to international talents , encourage innovation and development of chinese science and technology ; actively guide and create venture capital market , and provide multidimensional access to finance for biotechnological industry
  这一战略目标的实现应以“合作开发、改进创新、市场细分和成本最小”为主要方向，分三步完成。同时指出政府为发展中国医药生物技术产业，应在制定产业发展政策、强化国家科技创新体系建设、加强知识产权保护、鼓励基础性创新研究和产业化研究相结合、制定吸引世界性创新人才的政策以及培育风险投资市场等方面发挥更积极的作用。
• We should use this chance , establish an appropriate strategy and improve the innovation abilities of corporations . the long - term strategic target is to use about 10 years to complete the research for new medicines and then shift to " independent research and development " ; to be in the top level of the world for innovative research and development of new technology and new products in the biopharmaceutical industry ; to make china become the leading center for biotech innovation ; to set up an innovative mechanism with corporations to be the core body and relevant to the international competing situation and self developing disciplines of modern corporations ; to bring up a batch of entities with competing capacities in the market and independent exploitation abilities ; to be a leading country with great power in biotech industry . joint exploitation , improvement and innovation , dividing market into even smaller fractions , and cost minimization are the main conditions for realizing the strategic target
  本论文从分析国内外生物技术企业的发展环境和发展特点入手，阐述我国生物技术企业加强科技创新的重要性和可行性，结合国情现状研究我国生物技术企业的科技创新战略，提出我国医药生物技术产业的长期战略目标应该是“用十年左右的时间，完成新药研究向"自主研发"的转移，在新技术、新产品的创新性研发方面跻身世界医药生物技术产业的领先行列，将中国建设成为世界一流的生物技术创新中心，建立健全以企业为核心的适应国际医药竞争形势和现代企业自身发展规律的技术创新运行机制体系，培养一批具有市场竞争力和自主开发能力的骨干创新实体，成为世界生物技术产业强国" 。
• A group of pillar enterprises with self - developed hi - tech products have emerged in shenzhen , such as huawei technologies , zhongxing telecom , great wall and tianma microelectronics in the it industry , kexing co . in bio - engineering industry , analogue co . , our co . and mairui co . in medical equipment industry , and beyond co . and tianyu co . in the new materials industry
  深圳已形成一批具有自主知识产权产品的骨干企业，如电子信息产业的华为公司、中兴通讯公司、长城计算机公司、天马微电子公司；生物技术产业的科兴公司；医疗器械产业的安科公司、奥沃公司、迈瑞公司；新材料产业的比亚迪公司、天玉公司等。